Actively Recruiting
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2023-08-01
200
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.
CONDITIONS
Official Title
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years and older
- Male or female gender
- Diagnosed with Peripheral T-cell Lymphoma (PTCL)
- Received chidamide as maintenance therapy after first-line treatment
You will not qualify if you...
- Patients with other types of lymphomas
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hematological Department, People's Hospital of Jiangsu Province
Nanjing, Jiangsu, China, 210029
Actively Recruiting
Research Team
W
wei xu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here